- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-VEGFA
VEGFA Polyclonal Antibody for WB, IP, IF, IHC, ELISA, FC (Intra)
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (5)
Applications
WB, IHC, IF/ICC, FC (Intra), IP, RIP, ELISA
Conjugaison
Non conjugué
712
N° de cat : 19003-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A431, cellules Jurkat, cellules MCF-7 |
Résultats positifs en IP | cellules Jurkat, |
Résultats positifs en IHC | tissu de cancer du poumon humain, tissu de cancer du foie humain, tissu hépatique de souris, tissu pulmonaire de souris, tissu rénal de souris il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF/ICC | cellules HeLa, |
Résultats positifs en FC (Intra) | cellules NIH/3T3 |
Résultats positifs en cytométrie | cellules NIH/3T3, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:12000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochimie (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
Flow Cytometry (FC) | FC : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 13 publications below |
WB | See 32 publications below |
IHC | See 223 publications below |
IF | See 75 publications below |
IP | See 1 publications below |
RIP | See 1 publications below |
Informations sur le produit
19003-1-AP cible VEGFA dans les applications de WB, IHC, IF/ICC, FC (Intra), IP, RIP, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | rat, Chèvre, Humain, Lapin, porc, singe, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | VEGFA Protéine recombinante Ag13500 |
Nom complet | vascular endothelial growth factor A |
Masse moléculaire calculée | 412 aa, 46 kDa |
Poids moléculaire observé | 36-40 kDa |
Numéro d’acquisition GenBank | BC065522 |
Symbole du gène | VEGFA |
Identification du gène (NCBI) | 7422 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
VEGFA, also named VEGF or VPF, belongs to the PDGF/VEGF growth factor family. It is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. VEGFA induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. Defects in VEGFA are associated with microvascular complications of diabetes type 1 (MVCD1). VEGFA has 17 isoforms with MW from 16 to 45 kDa. Some isoforms have homodimer forms (e.g.; VEGFA189 38 kDa or VEFGA110 34 kDa). VEGF-A exists in at least seven homodimeric isoforms. The monomers consist of 121, 145, 148, 165, 183, 189, or 206 amino acids (PMID:15602010 ). This antibody can recognize all VEGFA isoforms.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for VEGFA antibody 19003-1-AP | Download protocol |
IHC protocol for VEGFA antibody 19003-1-AP | Download protocol |
IF protocol for VEGFA antibody 19003-1-AP | Download protocol |
IP protocol for VEGFA antibody 19003-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nat Nanotechnol Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades.
| ||
Bioact Mater A bioactive composite hydrogel dressing that promotes healing of both acute and chronic diabetic skin wounds | ||
ACS Nano Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Mitochondrial Damage and Inflammation by Stabilizing Mitochondrial DNA. | ||
Biomaterials A nano-conductive osteogenic hydrogel to locally promote calcium influx for electro-inspired bone defect regeneration | ||
Light Sci Appl Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer's disease mouse model. | ||
J Clin Invest Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema. |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Angie (Verified Customer) (07-24-2024) | WB result of VEGFA antibody (used at 1:5000) incubated at room temperature for 1.5 hours. Two stronger bands between 35-50 kDa were observed.
|
FH Alexandru (Verified Customer) (11-21-2023) | Great antibody with clear and specific signal, would buy again!
|
FH Fiona (Verified Customer) (07-16-2019) | Good quality antibody and good value for money. Would purchase again.
|